1
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, June 17, 1997: US05639476 (566 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


2
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtigue, Steinberg Raskin & Davidson, April 16, 1996: US05508042 (273 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


3
Benjamin Oshlack, Frank Pedi Jr, Mark Chasin: Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer. Euroceltigue, Steinberg & Raskin, December 28, 1993: US05273760 (259 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active agent with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature a ...


4
Benjamin Oshlack, John J Minogue, Mark Chasin: Controlled release oxycodone compositions. Euroceltique, Steinberg & Raskin, November 30, 1993: US05266331 (259 worldwide citation)

A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 ...


5
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Stabilized controlled release formulations having acrylic polymer coating. Euroceltique, Steinberg & Raskin, February 15, 1994: US05286493 (258 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of an acrylic polymer is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of the plasticized acrylic polymer and then curing the coated substrate at ...


6
Benjamin Oshlack, Mark Chasin: Orally administrable opioid formulations having extended duration of effect. Purdue Pharma, Davidson Davidson and Kappel, October 19, 1999: US05968551 (257 worldwide citation)

Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for at least about 24 hours. A unit dose of the opioid analgesic contains a plurality of substrates includin ...


7
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 27, 1996: US05549912 (248 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


8
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled-release formulations coated with aqueous dispersions of ethylcellulose. Euroceltique, Steinberg Raskin & Davidson, December 5, 1995: US05472712 (247 worldwide citation)

A stabilized solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic polymer is obtained by overcoating a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic ...


9
Benjamin Oshlack, Mark Chasin, John Joseph Minogue, Robert Francis Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 12, 1997: US05656295 (234 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


10
Benjamin Oshlack, Mark Chasin, Hua Pin Huang: Extruded orally administrable opioid formulations. Euro Celtique, Davidson Davidson & Kappel, September 28, 1999: US05958452 (230 worldwide citation)

Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.



Click the thumbnails below to visualize the patent trend.